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Abstract 1 
Temporary manipulation of bacterial polyphosphate levels by phased environmental 2 
stimuli underlies wastewater biological phosphate removal processes. In E. coli 3 
polyphosphate levels are controlled via polyphosphate kinase (PPK1, synthesizing) and 4 
exopolyphosphatases (PPX and GPPA), and are temporarily enhanced by PPK1 5 
overexpression and reduced by PPX overexpression. We hypothesised that partitioning 6 
PPK1 from cytoplasmic exopolyphosphatases would increase and stabilise E. coli  7 
polyphosphate levels. Partitioning was achieved by coexpression of E. coli PPK1 fused 8 
with a microcompartment-targeting sequence and an artificial operon of Citrobacter 9 
freundii bacterial microcompartment genes. Encapsulation of targeted PPK1 resulted in 10 
stably increased cellular polyphosphate and persistent net phosphate cellular uptake into 11 
stationary phase, while temporary polyphosphate increase and phosphate uptake was 12 
observed with PPK1 overexpression alone. Targeted PPK1 increased polyphosphate in the 13 
microcompartment fraction 8-fold compared with non-targeted PPK1. Co-expression of 14 
PPX and non-targeted PPK1 abolished any increase in cellular polyphosphate from PPK1 15 
expression alone. Co-expression of PPX with targeted PPK1 however resulted in elevated 16 
polyphosphate levels due to persisting polyphosphate in bacterial microcompartments. 17 
Subcellular polymerising enzyme targeting to bacterial microcompartments sequesters 18 
metabolic products from competing catabolism by preventing catabolic enzyme access. 19 
Specific application of this process to polyphosphate is of potential application for 20 
biological phosphate removal.  21 
 22 
 23 
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1. Introduction 1 
Polyphosphate is a molecule thought to be present in all organisms [1] playing a role in 2 
cellular metabolic processes, stress response processes, virus replication and cell structure 3 
[2]. Bacterial polyphosphate accumulation underlies the enhanced biological phosphorus 4 
removal (EBPR) process, which uses microorganisms to remove inorganic phosphate (Pi) 5 
from wastewater [3]. Phosphate recovery processes are required to reduce eutrophication, 6 
the overgrowth of cyanobacteria and plants in water polluted by excess phosphorus from 7 
human activity [4], and because of the unsustainability of current phosphorus resources 8 
beyond the next century [5]. In EBPR, cycling of wastewater  sludge through aerobic and 9 
anaerobic phases of incubation lasting several hours, when continued over a period of 10 
weeks selects a bacterial consortium that has a net effect of removing phosphorus from 11 
wastewater over the cycle by accumulating it in the sludge. Polyphosphate-accumulating 12 
bacteria are key consortium components [6, 7]. Phosphate release from the consortium 13 
occurs in the anaerobic phase in parallel with consumption of volatile fatty acids, 14 
polyhydroxyalkanoate polymer formation  and glycogen utilisation. In the aerobic phase 15 
stored polyhydroxyalkanoate is catabolised, glycogen replenished and phosphate taken up 16 
to form polyphosphate granules [7]. EBPR is a complex dynamic process - an uncultured 17 
bacterium Candidatus Accumulibacter phosphatis performs a key role in EBPR 18 
polyphosphate accumulation [8], and an established EBPR reactor may fail for unknown 19 
reasons [3, 9]. 20 
 21 
Genetic manipulation of aspects of phosphate binding, uptake and storage by a single 22 
model organism such as E. coli has been suggested as an alternative or additive approach 23 
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to biological phosphorus removal [10–13]. One issue with over-expression of a 1 
polyphosphate forming enzyme in E. coli has been that most of the consequent increase of 2 
polyphosphate is temporary, probably because of the existence of competing catabolic 3 
enzymes [14, 15] and phosphate release from the cells then occurs as the polyphosphate is 4 
broken down. 5 
 6 
In E. coli polyphosphate kinase PPK1 (E.C. 2.7.4.1) is the enzyme responsible for 7 
assembling inorganic polyphosphate polymers in the bacterial cytoplasm by catalysing the 8 
reaction nATP ⥂ (polyphosphate)n + nADP [16, 17]. Although this is a reversible reaction, 9 
in E.coli this enzyme generally favours synthesis of polyphosphate over breakdown (Vmax 10 
ratio of 4.1) [17] (Fig.1A). However, the balance between net accumulation and breakdown 11 
changes dynamically during culture growth and also in response to external stimuli, in part 12 
due to the action of degradative exopolyphosphatases. In this respect E. coli contains two 13 
such polyphosphatases that release orthophosphate from the termini of long chain 14 
polyphosphate: (polyphosphate)n → (polyphosphate)n-l + Pi. The two polyphosphatases 15 
are called PPX (E.C. 3.6.1.11, sometimes referred to as PPX1) [18, 19], which is encoded 16 
in the same operon as PPK1, and its homologue guanosine pentaphosphate 17 
phosphohydrolase (GPPA or PPX2) [17, 20]. GPPA (E.C. 3.6.1.40) also hydrolyses 18 
guanosine pentaphosphate (pppGpp) to guanosine tetraphosphate (ppGpp) with phosphate 19 
release as part of the control of the stringent response. Both PPX and GPPA are 20 
competitively inhibited by pppGpp [21]. Consequently, amino acid starvation in E. coli 21 
leads to the accumulation of large amounts of polyphosphate due to the high levels of 22 
pppGpp produced as part of the stringent response [21]. In E. coli ppk1 and ppx are adjacent 23 
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genes forming an operon and knockout of ppx alone has been engineered by combined 1 
knockout of ppk1 and ppx with heterologous plasmid expression of ppk1 [15, 22, 23]. 2 
Elevation of polyphosphate levels in these cells rapidly declines a few hours after ppk1 3 
plasmid induction whether ppx is active or knocked out [15], showing that PPX is not the 4 
sole cause of instability in polyphosphate levels in E. coli. We hypothesized that an 5 
alternative approach to prevent the access of all other cytoplasmic enzymes, (not just PPX) 6 
to polyphosphate formed from recombinant PPK1 would stabilise cellular polyphosphate 7 
levels and create a phosphate-retaining phenotype. The mechanism used to achieve this is 8 
targeting of PPK1 to a recombinant bacterial  microcompartment.  9 
 10 
Bacterial microcompartments (BMCs) are proteinaceous vesicles found in certain bacteria 11 
that house specific metabolic pathways encased within a closed polyhedral shell of 100-12 
150 nm diameter. The shells are made of thin protein sheets [24] containing pores less than 13 
1 nm in diameter [25] which can be positively or negatively charged. There are two broad 14 
groups of BMCs, those associated with the anabolic process of RuBisCO-mediated carbon 15 
fixation (carboxysomes) and those associated with catabolic fermentative processes such 16 
as 1,2-propanediol utilisation (metabolosomes) [26, 27]. Although BMCs were first seen 17 
over fifty years ago in photosynthetic cyanobacteria [28], their presence in the cytoplasm 18 
of heterotrophic bacteria was only confirmed in 1998 [29] after they were detected in thin 19 
sections of Salmonella enterica grown on 1,2-propanediol. In fact, around twenty per cent 20 
of bacterial genome sequences contain BMC structural genes [26], in many cases 21 
associated with enzymes of unknown function [30]. 22 
 23 
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A significant proportion of bacteria therefore make a major investment in retaining and 1 
expressing large (15+ gene) operons encoding these structures and associated enzymes. It 2 
is believed the structures help mediate metabolic efficiency by selective limitation of the 3 
shell pores on the passage of substrates [31], by metabolite channelling, or other 4 
mechanisms achieving retention of reaction intermediates within the structure [32, 33]. 5 
Salmonella enterica Serovar Typhimurium accrues a competitive metabolic advantage by 6 
BMC-mediated respiration of ethanolamine in a mouse colitis model [34]. 7 
Enterohaemorrhagic E. coli obtains a similar competitive advantage from BMC-mediated 8 
ethanolamine fermentation in bovine intestinal fluid [35], favouring persistent intestinal 9 
carriage. 10 
 11 
Recombinant BMCs using genes from Citrobacter freundii can be expressed 12 
heterologously in E. coli [36], both with and without [37] the associated interior enzymes. 13 
Peptide sequences enabling enzyme localisation to the BMC interior have been identified 14 
[37] [38]. For instance, the first 18 amino acids of PduP, P18, or the first 18 or 60 amino 15 
acids of PduD (D18 or D60) can be used as fusions to direct “foreign” proteins into the 16 
BMC [39]. Compartmentalisation of the cellular interior is a functionally transforming 17 
process often thought of as  characteristic of eukaryotes [40], but specific localisation of 18 
any enzyme to a re-engineered BMC in bacteria could increase metabolic flexibility of the 19 
bacterial host enabling novel phenotypes [41]. Nanotechnological applications of other 20 
biological compartment systems have included the use of viral capsids for DNA delivery 21 
[42], lumazine synthase enclosure of HIV protease [43], and the engineering of novel 22 
metabolites. We hypothesized that directing PPK to a BMC would enhance polyphosphate 23 
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formation within a cellular compartment and that segregation from the known degradative 1 
polyphosphatases and other cytoplasmic enzymes should stabilise accumulation of 2 
polyphosphate (Fig.1).  3 
 4 
2. Materials and Methods 5 
Strains, plasmids and culture conditions 6 
E. coli was grown in LB or MOPS medium [44] with either 0.5 mM or 1.0 mM K2HPO4 7 
as indicated. Expression of pET cloned genes was induced by IPTG in E. coli BL21 (DE3) 8 
and E. coli BL21 Tuner (DE3) (Novagen). Strains and plasmids are listed in Table 1 and 9 
oligonucleotides in Supplementary Data Table S1. Incubation for phosphate uptake 10 
experiments was at 37 °C, otherwise pDuet inductions were incubated at 18 °C.  11 
 12 
Molecular techniques 13 
Plasmid cloning was carried out in E. coli JM109 or E. coli TOP10 (Invitrogen) with 14 
subsequent transfer to E. coli BL21 (DE3) and E. coli BL21 Tuner (DE3) for expression 15 
using standard transformation techniques [45]. For PCR experiments standard protocols 16 
were applied using an MJ Research PTC-200 Thermal Cycler for reaction cycles. Genomic 17 
DNA was extracted from E. coli JM109 using a Wizard® Genomic DNA Purification Kit 18 
(Promega). Plasmid constructs were sequenced commercially (GATC Biotech).  19 
 20 
Targeting of PPK1 21 
The strategy used is summarised in Supplementary Data Fig.S1. The ppk1 gene coding for 22 
polyphosphate kinase (PPK1) was PCR-amplified with a proofreading DNA polymerase 23 
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(Bioline High Velocity Polymerase, Bioline UK, London), using genomic DNA from E. 1 
coli JM109 as template, using the forward primer ppk1-F and a reverse primer ppk1-R 2 
(Table S1). The PCR product was digested with Sac I and Hind III (Fermentas) followed 3 
by ligation to pET23b-GFP-pduP18 digested with Sac I and Hind III. The gene encoding 4 
the GFP was thus replaced by ppk with retention of the pdu localization sequence. The 5 
ligation product was transformed into E. coli Top 10 electrocompetent cells (Invitrogen) 6 
by electroporation. The new vector, named pML001 (pET23bpduP18-ppk1), was extracted 7 
and the ppk1 insert was sequenced (GATC-Biotech) to confirm no mutation had occurred. 8 
Two constructs, pML001 and pLysSpduABJKNU (pSF37), expressing an empty pdu BMC 9 
[37]), were co-transformed into E. coli BL21 (DE3) by heat shock. 10 
 11 
Co-localisation of PPK1 and Microcompartments  12 
 13 
Peptide fingerprinting of microcompartment cellular fraction 14 
Recombinant BMCs were extracted from E. coli by a modification of a published method 15 
[46]. A single colony pick was grown in 200 ml of LB to an OD of 0.4 followed by 16 
induction with 0.4 mM IPTG. Cells at OD1.0-1.2 were harvested and washed twice with 17 
40 ml of buffer A (50 mM Tris-HCl (pH 8.0), 500 mM KCl, 12.5 mM MgCl2, 1.5% 1,2-18 
PD). Cells (1 g wet weight) were resuspended in a mixture of 10 ml of buffer A and 15 ml 19 
of BPER-II supplemented with 5mM mercaptoethanol, Complete Protease Inhibitor 20 
Cocktail (Roche) at the manufacturer’s recommended working dilution, 25 mg of 21 
lysozyme, and 2 mg of DNase I. The suspension was incubated for 30 min on a shaking 22 
incubator at room temperature and on ice for 5 min. After initial removal of cell debris by 23 
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centrifugation at 12,000 g for 5 min at 4°C repeated twice, the BMC fraction was 1 
precipitated by spinning at 20,000 g for 20 min at 4°C. The pellet was washed once with a 2 
mixture of 4 ml of buffer A and 6 ml of BPER-II and resuspended in 0.5 ml of buffer B 3 
(50mMTris-HCl pH 8.0, 50 mM KCl, 5 mM MgCl2, 1% 1,2-PD) containing Complete 4 
Protease Inhibitor Cocktail (Roche) at the manufacturer’s recommended working dilution. 5 
Remaining cell debris was removed by centrifugation for 1 min at 12,000 g 4°C repeated 6 
three times. A -PAGE using a 7 
15% polyacrylamide gel under denaturing conditions in a MiniProtean apparatus (Bio-Rad) 8 
and stained with Coomassie Brilliant Blue R250 (Fig.1B). Peptide fingerprinting carried 9 
out as previously described [47]. In microcompartment extraction for ATP regeneration 10 
assays (Fig. 1C,D) and whole cell polyphosphate assays (Fig 2) CelLytic B (Sigma-11 
Aldrich) was initially substituted for BPER-II because of published efficacy of this reagent 12 
for polyphosphate extraction [48]. In later microcompartment extractions (Fig. 3) 13 
comparisons of BPER-II extractions and CellLytic B extractions had shown little 14 
difference in measured polyphosphate levels and BPER-II was used. Micrococcal nuclease 15 
2 mg (Sigma-Aldrich) prepared with calcium buffer was substituted for DNase 1 for all 16 
microcompartment extractions where polyphosphate was assayed because of the potential 17 
adverse effect of Mg2+ containing buffers on polyphosphate [49]. 18 
ATP regeneration assay  19 
A combination of two previously described PPK1 assay methods [48, 50] using luciferase 20 
to detect ATP produced from polyphosphate by PPK1 was used as a biochemical screen 21 
for the presence of PPK1 and polyphosphate in microcompartment fractions. Briefly, to 22 
 23 
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containing: ultrapure ADP (ATP-free, Cell Technology Inc, Ca), 30 mM MgCl2, 1% (w/v) 1 
Polyphosphate (Sigma), 50 mM Tris-HCl (pH 7.8). The reaction mixture was diluted 1:100 2 
in 100 mM Tris-HCl (pH 8.0)–4 mM EDTA, of which 0.1 mL was added to 0.1 mL of 3 
luciferase reaction mixture from ATP Bioluminescence Assay Kit CLS II (Roche). 4 
Luminescence was measured by using a luminometer (Luminoskan, Thermo Labsystems). 5 
A standard curve for ATP by dilution in 100 mM Tris-HCl (pH 8.0) containing 4 mM 6 
EDTA was used. To assay relative polyphosphate content, the same reaction omitting 7 
added polyphosphate was performed (Figure 1C). 8 
 9 
Co-expression of targeted and untargeted PPK1 and PPX 10 
The pCOLADuet-1 coexpression vector (Novagen) system encoding two multiple cloning 11 
sites (MCS) each preceded by a T7 promoter, lac operator, and ribosome binding site was 12 
used to express targeted and untargeted E. coli PPK1 and PPX (ppx amplified from E. coli 13 
JM109) in combination (pYY005, pYY007, pYY008) and alone (pYY002, pYY010) (see 14 
Table 1).  15 
Polyphosphate concentration presented in Fig. 3 was determined following lysis of pelleted 16 
cells from 10 ml of cultures described above. A metachromatic assay was employed using 17 
the 530/630nm absorbance ratio of 10 μL of lysate added to 1 mL of toluidine dye solution 18 
(6 mg/L toluidine blue in 40 mM acetic acid) as described [51]. In later experiments (Fig. 19 
4) polyphosphate was determined by a higher-yielding method using 4’-6-diamidino-2-20 
phenylindole (DAPI) as described [52] on whole cells or microcompartment cell fractions 21 
obtained with BPER-II extraction. Briefly, cells were harvested by centrifuging at 5000g 22 
for 10 min at 4° C. After washing in 50mM HEPES buffer (pH7.5) the cell pellet or 23 
Promoting stable polyphosphate accumulation in E. coli. Liang et al 
 
11 
microcompartment fraction was frozen at -20° C followed by defrosting at room 1 
temperature. Cell pellets/microcompartment fractions were resuspended in HEPES buffer 2 
at an appropriate dilution to ensure that the cellular polyP concentration was in the linear 3 
range of the DAPI assay (0-4 
100 µL of polyP containing samples and 200 μL of DAPI assay buffer containing 150 mM 5 
KCl, 20 mM HEPES-KOH (pH 7.0) and 10 μM DAPI solution. After a 10 min incubation 6 
at room temperature DAPI fluorescence was measured with a platereader equipped with 7 
excitation and emission filters of 420 nm and 550 nm respectively.  8 
 9 
A polyphosphate standard curve was prepared using sodium phosphate glass Type 45 10 
(S4379 Aldrich) and sodium hexametaphosphate (SX0583). Protein concentration of cell 11 
extracts was measured using a 10μL sample, with Coomassie Plus Protein Assay Reagent 12 
(Pierce) with bovine serum albumin as the standard resuspended in the same buffer as the 13 
sample.  14 
 15 
Phosphate uptake was determined as follows (Fig. 2A). Bacteria was grown to OD600 0.4-16 
0.6 in Luria broth and then induced by 0.5 mM of IPTG for 1 hr before transfer to pH 5.5 17 
MOPS medium [44] containing 0.01 mM iron and 0.5 mM potassium phosphate, at an 18 
OD600 of 0.2. Incubation was continued at 37°C with intermittent sampling of 0.2 mL up 19 
to 48 hrs. Samples were centrifuged and supernatant used for phosphate assay, and the 20 
pellet used for polyphosphate and protein assays. Phosphate was assayed using a 21 
molybdovanadate colorimetric method [53]. 0.2 mL of molybdovanadate solution 22 
(Reagecon, cat no: 1056700) was added to 5 mL of culture supernatant, mixed and 23 
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incubated at room temperature for 5 min. Optical density of 1 mL at 430 nm was measured 1 
against a blank of 4% molybdovanadate in distilled water and a calibration curve of 2 
potassium phosphate in MOPS.  3 
 4 
Light Microscopy 5 
Polyphosphate granules were visualised in fixed films (Fig. 4) by Neisser’s stain using 6 
Chrysoidin counterstain [54]. 7 
 8 
Electron Microscopy 9 
E. coli BL21(DE3) cells containing targeted/untargeted PPK1 and pLySsPduABJKNU (for 10 
expressing empty microcompartments) were grown in 50 mL of LB broth containing 100 11 
mg/litre ampicillin and 32 mg/L chloramphenicol with shaking at 37 °C. Upon reaching an 12 
OD600 of 0.5, protein production was induced with 0.5 mM isopropyl-D-thiogalactoside, 13 
and the cultures were incubated by shaking overnight at 18 °C. Harvested cells were 14 
resuspended in 2 mL of fixative consisting of 2.5% glutaraldehyde in 100 mM sodium 15 
cacodylate (CAB) buffer (pH 7.2). The cells were pelleted and washed twice with CAB to 16 
remove traces of the fixing solution. Cells were then stained for 1 hr in 1% osmium 17 
tetroxide (w/v) and washed with CAB before dehydration. Dehydration was carried out by 18 
placing the samples into an ethanol gradient: 50%, 70%, 90% once for 10 minutes, and 19 
100% dried ethanol three times for 15 minutes. Samples were rinsed twice for 15 minutes 20 
in propylene oxide and then incubated in 50/50 propylene oxide/Agar LV resin for 30 21 
minutes. Samples were incubated 2 x 2 hr in fresh Agar LV resin before embedding in 22 
Beem capsules by centrifugation at 11,000 rpm for 5 minutes followed by incubation at 60 23 
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°C overnight to polymerize. Specimens were thin sectioned with a diamond knife on an 1 
RMC MT-6000-XL ultramicrotome, collected on 400 mesh copper grids, and post-stained 2 
with 4.5% uranyl acetate for 45 min at RT and lead citrate for 7 min at RT. Sections were 3 
then observed and photographed with a JEOL-1230 transmission electron microscope at 4 
an accelerating voltage of 80 kV. 5 
 6 
Electron microscopy for parallel electron energy loss spectroscopy (PEELS) and 7 
element mapping by electron spectroscopic imaging (ESI) 8 
Unstained cells were fixed in 3% (v/v) glutaraldehyde – 10 mM Hepes, pH 7.3 (Sigma), 9 
dehydrated in an acetone-series and embedded in epoxy resin (Spurr, hard mixture; [55]), 10 
as described [56]. For elemental analysis 30 - 40 nm ultrathin sections (otherwise 90 nm 11 
for general ultrastructure) were sectioned with a Reichelt-Jung ultramicrotome (Leica, 12 
Vienna, Austria), equipped with a diamond knife and were picked up with 300 mesh Cu-13 
grids. Electron micrographs were recorded in the elastic brightfield mode (slit width: 10 14 
eV) with an EF-TEM (operated in general at 120 kV acceleration voltage), equipped with 15 
an in-column Omega-type energy filter (LIBRA120 plus, Zeiss, Oberkochen Germany), in 16 
a magnification range from x 4000 to x 32000 with a bottom-mount cooled 2048 x 2048 17 
CCD camera (sharp:eye; Tröndle, Moorenweis, Germany).  18 
 19 
Parallel electron energy loss spectroscopy (PEELS) 20 
Spot-PEELS were recorded within electron dense cytoplasmic inclusion bodies. Spot-size 21 
was set to 16 nm and the objective aperture was 60 μm (spectrum magnification: x100; 22 
energy range: 67 – 290 eV; recording time: 10 s ; emission current: 1 μA) and the spectrum 23 
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energy resolution was about 1.6 eV at zero-loss (FWHM). Recorded PEELS data were 1 
corrected for background, applying the ‘potence’ underground function of the EsiVision 2 
Pro Software (EsiVision Pro, Vers. 3.2; SIS – Soft Imaging Systems, Munster, Germany) 3 
and were ‘medium’-filtered (settings: 1.5 eV width). 4 
 5 
Element mapping by electron spectroscopic imaging (ESI) 6 
Phosphorus mapping was performed as previously described [56] with unstained 35 nm 7 
ultrathin sections. According to the '3-window method' energy-windows were set to a 8 
dedicated energy loss for the P-L23 edge, as it was given by the corresponding first 9 
intensity maximum from the spot-PEELS, i.e. 138 eV (W1: 125 eV; W2: 115 eV). The 10 
energy selective slit was set to 6 eV width, and images were recorded with an illumination 11 
aperture of 0.63 mrad, an emission current of 1 μA, a 60 μm objective aperture, and a 12 
nominal magnification of x 6300. Background subtraction for calculating the phosphorus 13 
element map was performed by the ‘multiwindow exponential difference’ method.  14 
 15 
3. Results 16 
BMC localisation of PPK1  17 
The localisation of PPK1 to a recombinant BMC was achieved by engineering the fusion 18 
of the P18 targeting peptide to the N-terminus of the enzyme. The recombinant BMC with 19 
the associated P18-PPK1 was isolated after lysis of the cells using a protein extraction 20 
reagent followed by differential salt precipitation and centrifugation. Analysis of the 21 
purified BMC fraction by SDS-PAGE revealed the presence of P18-PPK1 together with 22 
the BMC-associated shell proteins (Fig. 1B).  23 
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 1 
A functional assay designed to maximise PPK1’s ATP breakdown function was employed 2 
to determine the activity of PPK1 when it was directed to the BMC. In comparison to BMC 3 
extracts from cells producing only empty BMCs or empty BMCs and non-targeted PPK, 4 
the purified BMC cell fractions from the cells co-producing BMCs and P18-PPK1 5 
generated over twenty-fold more ATP per mg of protein from added polyphosphate 6 
(Fig.1C). There was little activity in the equivalent protein fraction that had been prepared 7 
from cells producing only P18-PPK1 (i.e. P18-PPK1 produced in the absence of BMCs). 8 
This showed that polyphosphate kinase activity had been transferred to the 9 
microcompartments by enzyme targeting.  10 
 11 
The same ATP regeneration assay was run again but this time in the absence of any added 12 
exogenous polyphosphate (Fig.1D). Any ATP generated in this assay would therefore 13 
reflect the amount of endogenous polyphosphate within the fraction. The BMC fraction 14 
from the cells that co-produced both the BMCs and P18-PPK1 generated more than twice 15 
as much ATP as control BMC fractions from cells expressing empty BMCs or BMCs with 16 
non-targeted PPK1 (Fig. 1D). This result indicates that the BMC fraction from cells co-17 
expressing targeted PPK1 had increased levels of polyphosphate, compatible with 18 
localisation of PPK1 to the microcompartment and formation of polyphosphate in situ. 19 
 20 
PPK1 targeting effect on polyphosphate content and phosphate uptake, 21 
The effect of PPK1 overexpression on cellular polyphosphate was both qualitative and 22 
quantitative, and targeted PPK1 with co-expressed BMCs gave a distinct phenotype. DAPI 23 
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negative staining of polyphosphate extracts, size-separated on a PAGE gel (Supplementary 1 
Data Figure S2), showed that the polyphosphate detected in strains over-expressing either 2 
p18ppk1 alone or p18ppk1 and pduABJKNU exceeded the length of the sodium phosphate 3 
glass Type 45 polyphosphate control. This indicates that long chain polyphosphate is 4 
present in these strains. No qualitative difference in chain length was detected between 5 
these two clones but long chain polyphosphate in the E. coli strain over expressing p18ppk1 6 
and recombinant BMCs persisted to a later phase of growth (Fig. S2) than in cells 7 
expressing p18ppk1 alone. No long chain polyphosphate was detected in the E. coli control.  8 
  9 
A simultaneous assay of the cellular polyphosphate and phosphate content of the culture 10 
supernatant from the cultures used in the polyphosphate chain length assay was also 11 
undertaken. Here, increased phosphate uptake from culture medium was observed in 12 
comparison to the host E. coli control (Fig. 2A) by both the p18ppk1-expressing strain and 13 
the strain expressing both p18ppk1 and pduABJKNU. A maximal uptake of approximately 14 
0.25 mM at 20 hours was observed for both constructs. However, the p18ppk-expressing 15 
strain returned a third of this phosphate to the supernatant after 48 hours, while the strain 16 
expressing both p18ppk1 and pduABJKNU returned less than 9% of phosphate taken by 48 17 
hours. Correspondingly, the cell associated polyphosphate levels of the p18ppk1 clone 18 
were maximal at 20 hours and declined thereafter, while the p18ppk1 and pduABJKNU 19 
expressing strain retained approximately the same level of cell associated polyphosphate 20 
at 48 hours as at 20 hours.  21 
 22 
BMC protects endogenous polyphosphate from exogenous polyphosphatases 23 
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The induction of non-targeted PPK1 from the pDuet vector increased whole cell 1 
polyphosphate levels 5-fold in comparison to control cells containing the BMC shell 2 
protein operon and the pDuet vector with no enzyme insert (the enzyme-free control, Fig. 3 
3). It did not increase the polyphosphate content of co-expressed recombinant 4 
microcompartments when compared to the enzyme-free control. However, P18-PPK1, 5 
when co-produced with the BMCs, increased polyphosphate levels in the BMC fraction 8-6 
fold in comparison to the enzyme-free control, while giving a similar overall 5-fold 7 
increase in whole cell polyphosphate to that seen with expression of non-targeted PPK1.  8 
 9 
Co-expression of non-targeted polyphosphatase PPX with non-targeted PPK1 reduced 10 
whole cell polyphosphate levels by 50% compared with non-targeted PPK1 expression 11 
alone, with little effect on polyphosphate levels in the microcompartment fraction. Co-12 
expression of non-targeted PPX and BMC-targeted P18-PPK1 reduced whole cell 13 
polyphosphate levels by 22% and BMC-associated polyphosphate by 18% when compared 14 
with microcompartment targeted PPK1 alone. BMC-associated polyphosphate was still at 15 
least 2.5 times greater than in cells co-expressing non-targeted PPK1 in the presence or 16 
absence of non-targeted PPX. Co-expression of BMC targeted P18-PPK1 with PPX 17 
targeted to the microcompartment using a different tag (D60) reduced the BMC-associated 18 
polyphosphate content by 50% in comparison to the BMC-targeted P18-PPK1 alone, while 19 
reducing whole cell polyphosphate by 22%. These data suggest that the BMC-targeting of 20 
PPK1 results in the synthesis of polyphosphate that is located primarily within the BMC 21 
fraction of the cell and is relatively inaccessible to cytoplasmic co-expressed PPX, but 22 
more accessible to BMC-targeted PPX.  23 
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 1 
Microscopy 2 
Blue-black granules were apparent with Neisser’s stain in a proportion of all cells 3 
overexpressing P18-PPK1, but not the E. coli BL21 insert-free control or without any 4 
targeted enzyme (Fig. 4). These appearances are consistent with the accumulation of 5 
intracellular polyphosphate in E. coli cells with increased PPK1 activity. All cells 6 
overexpressing P18-PPK1 showed a heterogeneous granule phenotype, with a proportion 7 
of non-toluidine blue staining cells in all fields.  8 
 9 
E. coli expressing the recombinant microcompartment and P18-PPK1 retained the 10 
polyphosphate staining at 44 hours (Fig. 4) whereas cells expressing P18-PPK1 without 11 
the recombinant microcompartment showed reduced staining after 40 hours (Fig. 3).  12 
All E.coli expressing the recombinant microcompartment had a proportion of cells which 13 
were greatly elongated. All E.coli forming multiple polyphosphate granules tended to be 14 
larger than the non-granulated cells, presumably because of distension by the granules. 15 
However, the largest cells were seen with the combination of recombinant 16 
microcompartment and P18-PPK1. 17 
 18 
Electron-loss spectroscopic analysis by Energy-filtered Transmission Electron 19 
Microscopy (EFTEM). 20 
 21 
Increased phosphorus deposition was detected in all cells expressing recombinant E.coli 22 
PPK1 (Fig. 5C,D,E,F), verified from PEELS measurement (see below), compared with 23 
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control E. coli strains with no recombinant gene expression (Fig. 5A) or expressing 1 
microcompartment genes (Fig. 5B). In cells expressing PPK1 alone, most phosphate signal 2 
was represented by particles <5 nm, but some large homogeneous masses > 200 nm with 3 
plane edges were visible (Fig. 5C) in a few cells. In cells expressing targeted PPK1 and a 4 
recombinant microcompartment operon, in addition to signals from particles <5 nm, 5 
multiple phosphate signals from particles 50-100 nm were present (Fig.5D,E,F) and in 6 
some cases large circular masses/crescents > 300 nm were present (Fig. 5D,F). These large 7 
masses were not homogeneous and appeared composed of small particles and the cells 8 
containing them were enlarged. These images appeared similar to light microscopy 9 
observations (Fig. 4D,H,L). 10 
 11 
Parallel electron energy loss spectroscopy (PEELS)  12 
Spot-PEELS recorded from dark inclusions apparent as electron dense regions about 100 13 
nm in diameter (Fig 5G), confirmed they contained phosphate, verified from the 14 
characteristic ELNES-fingerprint (Energy-Loss Near-Edge Structure) of reference spectra 15 
that were recorded from sodium polyphosphate (Fig.5G). The largest polyphosphate 16 
inclusion in figure 5E, shown in yellow, is magnified in the inset of the spot-PEELS (Fig. 17 
5G); here the 16 nm beam spot and its position are indicated (white circle).  18 
  19 
  20 
  21 
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4. Discussion 1 
Polyphosphate accumulation is the basis of the enhanced biological phosphorus removal 2 
(EBPR) process, which uses microorganisms to remove inorganic phosphate (Pi) from 3 
wastewater. Accumulation occurs in aerobic conditions as intracellular polyphosphate [8, 4 
12] is released as Pi in anaerobic conditions [57] and supplied with organic carbon or 5 
heated [12]. The best characterized enzyme responsible for polyphosphate synthesis 6 
(PPK1), originally found in E. coli [58], can only be detected by bioinformatics in the 7 
genome sequences of a minority of bacterial genera [59]. The enzyme responsible for 8 
polyphosphate synthesis in most bacteria therefore remains to be identified [59].  9 
 10 
In E. coli, polyphosphate accumulation in wild-type strains occurs with amino acid 11 
starvation or in the stationary phase [21, 50, 60]. Large amounts of polyphosphate 12 
accumulate only if the copy number of ppk is increased, or a heterologous ppk gene is 13 
supplied, or phoU is mutated [61]. Even in E. coli strains overexpressing ppk, initial 14 
accumulation of polyphosphate is known to be partially or completely reversed as the cells 15 
reach stationary phase [14, 15]. Because this also occurs in E. coli overexpressing ppk with 16 
no chromosomal functioning ppx gene it has been suggested to be due to either product-17 
induced reversal of the PPK-catalysed reaction, or the activity of another phosphatase 18 
enzyme present in the cytoplasm [15]. We observed a similar reversal of polyphosphate 19 
accumulation in our overexpressing ppk clone, accompanied by increasing Pi in the culture 20 
supernatant (Fig. 2). This did not occur when the ppk gene was engineered to encode an N-21 
terminal BMC localisation sequence and was expressed in trans with an operon encoding 22 
for an empty BMC.  23 
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 1 
Cells co-producing P18-PPK1 and the empty BMC had a different phosphorus distribution 2 
by EFTEM (Fig 5D,E,F) to those expressing PPK1 alone (Fig. 5C), containing single or 3 
agglomerated particles in the BMC size range. BMC extractions show the presence of 4 
metabolically active PPK1 (Fig.1C,D) and polyphosphate in the BMC fraction 5 
(Fig.1D,Fig.3) when PPK1 is microcompartment-targeted in this way. Our results suggest 6 
that targeting of PPK1 to a bacterial microcompartment still allows access of the small 7 
molecule substrate ATP to the enzyme (Figure 1A), but effectively stabilises the large 8 
polymer polyphosphate product (Fig. 2B,3). 9 
 10 
We hypothesized that this stabilisation results from reduced access of PPX, GPPA or 11 
other cytoplasmic phosphatases to the polyphosphate produced by BMC-targeted PPK1. 12 
To confirm this we carried out co-expression experiments of PPK1 with PPX (Fig. 3). 13 
Co-production of PPX with PPK1 resulted in lower cellular polyphosphate levels than 14 
expression of ppk1 alone (Fig. 3), as has been previously reported [62]. This reduction in 15 
total cellular polyphosphate was partially prevented by BMC-association of PPK1, due to 16 
increased levels of polyphosphate in the BMC fraction. BMC-targeting of PPK1 therefore 17 
results in the synthesis of polyphosphate that is located primarily in the BMC fraction of 18 
the cell. Polyphosphate in the BMC fraction is inaccessible to cytoplasmic co-expressed 19 
PPX. Adding BMC targeting to PPX (D60-PPX) co-expressed with targeted PPK1 (P18-20 
PPK1) partially reverses the increase in polyphosphate levels in the BMC fraction 21 
conferred by targeted PPK1, presumably by increasing access of the PPX to 22 
polyphosphate in the BMC fraction. This suggests that the mechanism of stabilisation of 23 
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polyphosphate conferred by BMC targeting of PPK1 involves reduced access by 1 
cytoplasmic phosphatases.  2 
 3 
Other examples of such macromolecular association of enzymes exist. A variant of 4 
lumazine synthase was recently employed to encapsidate HIV protease within an E. coli 5 
host [43] facilitating recombinant synthesis of this potentially toxic enzyme by separating 6 
it from the remaining cytoplasm. Lumazine synthase compartments are genetically 7 
unrelated to BMCs involved in catabolic metabolism, and form pentameric components 8 
form smaller 30-40 nm icosahedral structures that more closely resemble viral capsids [63]. 9 
The enzyme is bound to part of the shell molecule forming the inner surface by an 10 
electrostatic mechanism [43, 64], (N-terminal fusion displays it on the outside [65]). 11 
Enzymically active inclusion bodies can be formed within bacterial cells by C-terminal 12 
attachment of short self-assembling peptide sequences [66], or N-terminal fusion with a 13 
self aggregrating protein [67] but these enzymes are not enclosed within a structure 14 
accessed via pores. Subcellular localisation of enzymes catalysing successive reactions in 15 
a metabolic pathway to peroxisomes in fungi [68] or BMCs [39] can promote product 16 
formation.  17 
 18 
Our results demonstrate that P18-PPK1 is targeted to a recombinant BMC. The 19 
observation that polyphosphate accumulates within the BMC suggests that targeted PPK1 20 
is internalised within the structure and remains functional, generating polymeric product. 21 
ATP must be able to enter the recombinant BMC to allow it to act as one of the substrates 22 
for the P18-PPK1 enzyme (Fig. 1A). However, this is not surprising as the native Pdu 23 
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BMC must allow ATP access as it is required by PduO (located within the 1 
microcompartment) for the regeneration of the coenzyme form of cobalamin needed by 2 
the diol dehydratase complex [69]. The association of PPK1 with the BMC however 3 
leads to sequestration of the enzyme’s metabolic product, presumably because its size 4 
does not allow it to leave the BMC by the same route by which the enzyme substrate 5 
ATP arrived. Protection of the polyphosphate product from catabolism from cytosolic 6 
enzymes is therefore achieved, illustrating a general mechanism by which BMC can be 7 
used to re-engineer cellular metabolism. The specific polymer generated, polyphosphate, 8 
is an important intermediary in the enhanced biological phosphate removal (EBPR) 9 
process employing environmental bacteria to remove phosphate from wastewater [3, 12] 10 
and has industrial applications [70]. EBPR requires prolonged cycles of aerobic and 11 
aerobic incubation to operate. The ability to stabilise polyphosphate produced in a single 12 
growth phase so that phosphate is not returned to the cell exterior could lead to a 13 
streamlined process with a single phase of incubation. This would require transfer of the 14 
recombinant microcompartment and targeted enzyme from E. coli to a more 15 
environmentally robust organism.  16 
 17 
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Table 1 
Plasmids and strains used in this study 
 
*All inserts from E.coli JM109 unless specified  †From Citrobacter freundii  ▲From 
Aequorea victoria 
Plasmids and strains Genotype* Source 
Plasmids   
pET23b pBR322, T7 Ap Novagen 
pCOLADuet-1™ ColA ori lacI T7lac Kanr Novagen 
pET23b-GFPPduP18 pET23b with gfp▲ and 
pduP18† leader sequence 
Prof. Martin 
Warren, University 
of Kent 
pLysSPduABJKNU (pSF37) CamR , TetR pduABJKNU† [37] 
pML001 pET23b with pduP18†-ppk1 
fusion without gfp▲ 
This study 
pML002 pET23b-ppk1 This study 
pCOLADuetPPK (pYY002) pCOLADuet-1 with ppk1 This study  
pCOLADuetP18PPK (pYY010) pCOLADuet-1 with 
pduP18†-ppk1 fusion 
This study  
pCOLADuetPPXPPK (pYY005) pCOLADuet-1 with ppk1 
and ppx  
This study  
pCOLADuetP18PPKPPX 
(pYY007) 
pCOLADuet-1 with 
pduP18†-ppk1 fusion and 
ppx 
This study  
pCOLADuetD60PPXP18PPK 
(pYY008) 
pCOLADuet-1 with ppk1 
and pduD60†-ppx fusion 
This study  
   
Strains   
E.coli JM109 endA1 glnV44 thi-1 relA1 
gyrA96 recA1 mcrB+ Δ(lac-
proAB) e14- hsdR17(rK
-
mK
+) 
Promega 
E.coli Top 10 F- mcrA Δ(mrr-hsdRMS-
mcrBC) φ80lacZΔM15 
ΔlacX74 nupG recA1 
araD139 Δ(ara-leu)7697 
galE15 galK16 rpsL(StrR) 
endA1 λ- 
Invitrogen 
 
E.coli BL21 (DE3)  F- ompT hsdSB (rB
-
 mB ) gal 
dcm (DE3)  
Stratagene 
E.coli Tuner (DE3) F- ompT hsdSB (rB
-
 mB ) gal 
dcm lacY1 (DE3) 
Stratagene 
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Figure Legends 
 
Fig. 1. Effect of microcompartment-targeting of polyphosphate kinase (PPK1) in  E. coli  
A. Proposed mechanism of increasing polyphosphate content of E. coli by 
microcompartment-targeting of polyphosphate kinase (PPK1).  
B.  SDS-PAGE gel of E. coli BL21 (DE3) microcompartment extracts showing presence 
of PPK1 band. M:  MW marker. NE: no enzyme, microcompartment only, 
(pLysSPduABJKNU). PPK1 : non-targeted PPK1 plus microcompartment, pML2 
(ppk1) pLysSPduABJKNU. P18PPK1(2 lanes): microcompartment-targeted 
P18PPK1 fusion plus microcompartment, pML1 (p18ppk1) pLysSPduABJKNU. 
C & D. ATP generation assay with microcompartment fraction of E. coli BL21 (DE3) as 
substrate detecting polyphosphate kinase activity and polyphosphate when PPK1 is 
microcompartment-targeted. NE, PPK1, P18PPK1: as above. NS,P18PPK1: no shell, 
plasmid-located targeted PPK1 only, pML1 (p18ppk1). C: polyphosphate kinase (PPK1) 
assay with addition of ADP and polyphosphate. D: polyphosphate assay with addition of 
ADP alone.  
 
 
Fig. 2. Co-expression of targeted PPK1 and recombinant microcompartments in E. coli 
results in stable polyphosphate retention and orthophosphate uptake. Dashed line with 
filled circles: NS, E. coli BL21 DE3 control. Continuous red line with filled squares : 
NS,P18PPK1, no shell, plasmid-located targeted PPK1 only, E.coli BL21 DE3 pML01 
(p18ppk1). Continuous green line with filled triangles : S,P18PPK1, microcompartment-
targeted P18PPK1 fusion plus microcompartment shell E.coli BL21 DE3 pML1 (p18ppk1) 
pLysSPduABJKNU 
A. Supernatant orthophosphate levels. B. Whole cell polyphosphate content  
 
Fig. 3. Co-expression of microcompartment-targeted PPK1 and recombinant 
microcompartments in E. coli increases the polyphosphate content of the 
microcompartment fraction of lysed cells and protects it from  co-expressed cytoplasmic 
polyphosphatase 
DAPI polyphosphate assay from E.coli BL21 DE3 pLysSPduABJKNU all expressing 
recombinant microcompartments with different co-expressed enzymes. Blue bars 
polyphosphate content of microcompartment extractions, purple bars whole cell 
polyphosphate content. NE: no enzyme, microcompartment only, (pLysSPduABJKNU). 
S,PPK1 : non-targeted PPK1 and microcompartment, pML2 (ppk1). PPX,PPK1 : non-
targeted PPK1 and non-targeted PPX, pYY005 (ppk1 ppx).  D60PPX,P18PPK: targeted 
PPK1 and targeted PPK, pYY08 (ppk1 pduD60-ppx) . PPX,P18PPK1 : targeted PPK1 and 
non-targeted PPX, pYY07 (pduP18-ppk1 ppx). P18PPK1: targeted PPK1, pYY010 (pduP18-
ppk1)  
 
Fig. 4. Co-expression of targeted PPK1 and recombinant microcompartments in E. coli 
results in cytoplasmic polyphosphate granule formation persisting into stationary 
phase. Light microscopy of Neisser stained fixed cells (toluidine blue and chrysoidine 
counterstain. A,E,I: control E. coli BL21 DE3. B,F,J: E. coli BL21 DE3 NE: no enzyme, 
microcompartment only, (pLysSPduABJKNU). C,G,K E.coli BL21 DE3 pML01 (pduP18-
ppk1).   D,H,L BL21 DE3 pML01 (pduP18-ppk1) pLysSPduABJKNU. Incubation time in 
MOPS : A,B,C,D 4 hours, E,F,G,H 18 hours, I,J,K,L 44 hours.   
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Fig. 5. Phosphorus content of cytoplasmic granules in E. coli expressing recombinant 
polyphosphate kinase is confirmed by ultrastructural and electron-loss spectroscopic 
analysis  using energy-filtered transmission electron microscopy (EFTEM) and is 
increased and qualitatively altered by recombinant microcompartment co-expression  
A: control E. coli TunerTM(DE3). B: E. coli TunerTM (DE3) NE: no enzyme, 
microcompartment only, (pLysSPduABJKNU). C: E.coli BL21 DE3 pML01 (pduP18-ppk1). 
D,E,F,G: E. coli TunerTM (DE3) pET23bPduP18ppk1 pLySsPduABJKNU .  
A-F: Electron spectroscopic imaging. Phosphorus signals are shown as overlays: green in 
A,B,C Parallel electron energy-
loss spectroscopy (PEELS) of the largest granule in E. The red line represents SpotPEELS of 
the large inclusion from E with the spot (size: 16 nm) placed centrally (electron micrograph 
inset). The green-boxed area represents the P-L2,3 energy-loss near-edge structure (ELNES), 
characterized by the two peaks (asterisks). The blue-coloured dashed spectrum is referenced 
from sodium polyphosphate. 
 
 
 
